0 n/a 99 HeLa 107 Hela 200 HT-1080 292 kidney 308 HepG2 477 MN-1112 553 IMR-90 1292 HeLa S3 1315 KG-1 1323 A549 1331 HL-60 1379 HeLa 229 cells 1476 MRK-nu-1 1509 embryonic carcinoma NCR-G3 1530 WEHI-38 1606 SK-N-SH 1752 KE-4 1897 lymphoblastoid 1907 ME-1 1940 U937 1949 MKN28 2062 NCR-G3 2144 HUT102 2226 MCF-7 2976 primary culture 3041 KYSE410 3267 NUGC-3 3288 CaSki 3391 KSE-1 3408 Caco-2 4207 CMK86 4251 K562 4382 adenocarcinoma COLO 205 4495 UT-7 4525 TAPC301-CL4 4642 PAN07JCK 4712 KT-3 4743 NT2 5379 UT-M1 5456 Molt4 5461 Jurkat 5633 Molt-4 clone no.8 5656 G-361 5690 KB 5728 human gastric cancer cell line MKN-74 5747 bulk 5756 NALM6 5966 LAK cell 5988 HEK293 6057 HL-60 cells 6067 primary 6158 MDA-MB453 6186 HeLa cell 6249 293 cells 6264 RA-treated HL-60 6292 teratocarcinoma PA-1 7099 JHH7 7118 erythroleukemia cell 7229 Hela cell 7243 Jurkat cells 7376 Lymphoma Raji cell 7391 Colo 205 8082 KE4 8437 Y79 8516 MG63 8526 HeLa RCB0007 8542 THP-1 8569 COLO 205 8694 SK-MEL-37 9365 SW480 9595 HSC-45M2 9633 Jurkat cell 9695 primary-peripheral blood granulocytes 9754 KOCL-33 9763 HT1376 9863 teratocarcinoma; PA-1 9980 T-LAK cell 10142 Ntera-2 RA 10173 CHP134 10806 non-small cell lung cancer cell line, Ma29 10984 Human squamous carcinoma cell line 11098 U-2 OS 11170 HuS-L12 11253 PC-3 11270 Hep G2 11433 Jurkat, HeLa 12620 ACHN/CDDP 12629 HUT 78 12651 MKN45 12823 Daudi 12866 human promyelocytic leukemia cell line HL-60 13061 SCC-4 14972 HCS-2/8 14981 HPLF 14986 HEK 293 15001 Molt-4, T98G 15030 GLC-82 15038 T24 15049 WI-38 15060 interferon-gamma stimulated U937 cell line 15077 B cell line 15126 Ewing's sarcoma 15189 MDA-MB-231 breast cancer cells 15202 pre-B leukaemia cell line G2 15335 M426 15362 Hs68 15547 HUT78 T-cell leukemia 15760 UCLA-162 15782 KB-V1 15874 SK-1 15918 huvec; HS913T 15951 Epstein-Barr virus-transformed B cells 15987 T-47D 16076 leukemia U937 16093 SiSo 16145 Burkitt lymphoma cell line 16206 HO-1 16362 breast adenocarcinoma MCF7 16429 293 16454 MDA-MB-231 16459 MCF7; estrogen receptor-expressing 16466 LOX 16483 LNCaP 16531 KCNR 16547 HTLV-1 transformed T cell line, HAT109 16565 human-human hybridoma B9165 16576 CEM 16658 CB23 B lymphoblastoid 16672 MDA-MB-175 16893 ZR75-1 16919 EBV transformed lymphoblastoid 17013 acute myleoid leukemia (AML-M2) cell line 17127 DLD-1; colon cancer cell line 17246 NbHOT 17252 BT474 17259 NCI H69 17603 HaCaT 17772 IL-2 dependent polyclonal NK 17830 KG-1a; KG-1 17974 TF-1 18157 NCIH292 18244 Ntera-2/RA 18326 Ntera-2 18357 HCC II 18374 EnCa-MZ-3 18414 MES-SA/DxP 18470 NCI-H146 18477 MCF-7 and 5Y neuroblastoma cells 18543 EBV-transformed B-cell line KT 18549 EBV-transformed B-cell line CH 18663 MCF7 18888 B-cell 18950 HEL 19225 Jurkat T cell 19598 premyeloid cell line TF-1 19606 chemosensitive PA-1 cells; Wu,G.S. Nat. Med. 19679 MDA-MB-435 19706 lymphoblastoid JY1 cells 19869 76N 19967 HT1080 20180 Mieliki 20308 C3-A11N; Nalm-6 20327 HIMeg 20359 squamous carcinoma L-78 20517 pancreatic cancer Patu 8988t 20525 Patu 8988t 20578 HL60 and 293 20687 HeLa cells 20694 HBL-100 20706 immortalized first trimester trophoblast cells 20951 MDA-468 21055 HL60 21073 pancreatic adenocarcinoma 21138 lung type-I cell 21166 NCI-H82 21187 NCI H82; NCI H345 21219 T47D 21281 HAT109 21297 NCI H82 21342 KT3 21417 EBV transformed human B-cell line fused to 21622 HeLa S3; ATCC CCL2.2 21794 Mo7p210 21801 Hs578T 22146 Jurkat T-cell 22511 Jurkat T cells 22537 neuroblastoma SH-SY-5Y 22619 THP-1; phorbol ester-treated 4 days 22663 TIL 22858 HeLa-S3 22862 promyelocytic leukemia HL-60 cell line 23032 NB4 23676 BT-20 23837 D98-H2 HeLa 23850 MOLT-4 23880 neuroblastoma 4s 23899 HL-60 promyelocytic cell-line 23982 K-562 24079 3D5 24819 Jurkat cell line RPMI 1640 24853 endometrial adenocarcinoma cell line HEC1B 24942 KG1 24980 CHRF-288-11 25642 Epstein-Barr Virus transformed B cell 25775 HeLA S3 25791 JEG-3 choriocarcinoma 25859 HA1 25936 HTR-8/SVneo 26094 Caco2 26184 Caco 2 26739 monoclonal cell line Ha5C2.A2 26745 GM10618 26750 GM10354 26757 HPB-ALL 27070 U2OS 27184 NT2 neuronal precursor 27213 T84; CaCo-2; HT29 27305 MT2 27683 HOS8603 27690 8226; H929 27701 MM96 27893 ZR-75 28103 JAR 28138 AsPC-1 28288 UVB-treated HaCaT 28293 U937; ATCCCRL-1593 28300 HeLa S2 28393 LNCaP; C4-2 28420 F240 28450 CCL-156 28743 UOC-B1 28872 MDA-MB 28927 CaCo2 29926 Mueller 29994 Daudi; HeLa 30283 293T 30320 myelin basic protein-specific T-cell line 30542 promyelocytic leukemia HL-60 31108 HaCaT; TF-1 31132 leukemia TF-1 31156 MCF10A 31162 HT29 31353 LS180 31363 WiDr 31496 HUVEC 31576 monoclonal cell line SN66E3 from Arend Mulder, 31580 monoclonal cell line MBW1 32184 JEG-3 32216 erythroleukemia K562 32326 SCLC line NCI-H841 32343 UTMC2 32397 cancer cell lines 32861 NK92.26 32897 HeLa; Jurkat 33033 DAKIKI 33119 colonic adenocarcinoma SW480 33345 breast cancer cell line, BT474 33418 HMC-1 34108 Jar 34148 SKOV-3; taxol resistant line 34182 SS254 34193 C3-A11N; clonally related variant of OCI 34224 Epstein-Barr virus strain B95-8 transformed B 34282 acyte promyelocytic leukemia HT93A 34357 tumor cell line SOJ-6 34379 NT2-D1 34673 KG-1a 34775 Wish; HeLa 34908 mekakaryocyte 35009 CF-PAC1 35053 Gru-1 35251 acute myelogenous leukemia KG-1 36949 MM200 37051 GC 37074 OV177 37151 SMMU-7721 37579 H-460 37599 TC7 37958 1418-1 37964 1418-16 37968 1424 37975 T47-D 38009 HeLa, D98/AH-2, HPRT- 38023 SC-M1 38197 CEM174 38221 Raji 38348 Saos-2/B10 38389 ovarian epithelial cancer line SKOV-3 38452 184B5 38488 PancI 38511 10IHW 9022 38517 4AOH 100044V 38520 10IHW 9082 38523 10IHW 9013 38526 10IHW 9052 38529 4AOH 100083J 38532 10IHW 9090 38535 10IHW 9027 38538 10IHW 9041 38541 10IHW 9006 38544 4AOH 100108V 38571 HT-29/ino 38586 lymphoblast; prepared from SCA2 and SCA7 38604 breast cancer cell line 600PE 38616 Farage DLCL 38719 DU-145; PC-3 38724 Hodgkin cell line L428 38756 U-937 38845 KG1a 38914 MCF-7/AdrVp 39093 Ntera-2/c1.D1 39137 EBV-B 39245 SCC 9 39300 lymphoblastoid B-cell line NC37 39473 JME 41643 MCF-7/HER2 41674 EBV-transformed B cell; B-ALL 41779 BG9 41789 786-0 41934 SCC15;SCC25;FaDu 42101 SLB-I 42107 HTLV-I transformed T-cell line SLB-1 42374 CD8-1 42381 CD8-2 42389 DN1 42399 LDN5 42403 DN.POTT 42430 BjAB 42565 IgM Opp 03 42622 IgM FRI 42669 ZR-75-1 43156 IARC-EX1 43171 PMA stimulated HL60 43534 hepatoma 43584 Caco2-bbe 43611 ovarian cancer C200 43817 Saos-2 44692 COLO-205 44750 glioma U251 44897 Namalwa B cell lymphoma 45123 NCR-EW2 45971 JY 46189 DUPRO 46322 T84 46394 Jurkat T-cell leukemia 46766 SK-LMS-1 46800 E8CASS 46906 CCRF-CEM 46978 SP49 47033 Meg-01 47148 MDA-MD-468 47155 SOJ-6 47166 HT29-M6 transfected with an activated form of 47173 Nu-6-1 47620 NU-6-1 48111 L02 48137 A431 48508 SKOV-3 48808 NCI H157 48829 THP-1 monocyte-macrophage 49010 apoptotic HL-60 49074 subtype of SW 480 49188 SKN 49298 ECV304 49366 SUP-T1 49389 PC3 49495 K562, ATCC CCL-243 49498 CCRF-CEM, ATCC CCL-119 49501 KG-1a, ATCC CCL-246.1 49504 MOLT-4, ATCC CRL-1582 49527 glioma LNZ308 49584 Hela S3 50135 8701-BC; BT-474 50268 CFPac-1 51833 HT-29 51840 T84 colonic adenocarcinoma 51984 1973/10-4 52021 HT-29-M6 52034 ARPE-19 52103 SV40 virus-transformed embryonic lung 52248 LAN5 52459 SW626 52469 SCC-9 53964 MDA-MB-453 53976 HLE-B3 54021 leukemic T-cell line 54111 AHH-1 54182 melanoma cell line M88 54486 BB90-MEL 54647 K562 CML 54664 hepatoma Hep3B 54744 hepatoma cell line Hep3B 54758 697 54816 MDA MB 453 54970 ARCaP 55054 T84; HEk 293 55160 HCT-116 55573 DU145 55703 HCC 55765 F223 55784 LN319 55826 WERI-1 55832 Ramos 56017 MV4-11 56103 SLB-1 56368 TSUPr1 56853 HEK293; PC3 57101 Bix3 57120 1E8 57830 Hs638 57945 SS269 59176 pancreatic cancer cell line Suit S2 007 59188 LB373-MEL 59274 intestinal epithelial Caco2 59381 ovarian cancer line SKOV-3 59632 Caco-2; 407 59806 HD3 59865 GM11201 (Coriell) 59871 GM11197 (Coriell) 59966 Nalm6 60102 GM008333A (Coriell Cell Repositories) 60273 Dob1 hybridoma 60433 A431 epidermoid carcinoma 60487 MCF-7; T47D; ZR75-1; MDA-MB-453 60493 CEM x 174 (T-cell/B-cell hybrid) 60552 k562 60969 MOLT-4 T-cell lymphoblastic leukemia cell 60975 MOLT-4 T-cell lymphoblastic leukemia 61018 Mel JuSo 61383 MFC-7 61521 Lu-165 61532 Nu-6 61609 ARPE-19; from retina 61798 EA.hy926 61954 Burkitt's lymphoma 62109 H93D8 T cell 62115 Jurkat J6 T cell lymphoma 62182 MM5.1 multiple myeloma cell line 62285 NB4 treated by ATRA 62472 DJM-1 62556 Hl-60 62717 A2780 62745 T-84 63743 HaCat 63767 SiHa 63778 HeLa; WI38 63785 SK-N-MC 64533 U2OS; 978SK 64625 WERI Rb-1 64699 GT2015; GT1179 64705 IHW9001 SA; IHW9004 JESTHOM 64708 IHW9021 RSH; GT1261 64711 GT1060; GT1081 64714 IHW9251 M7 64717 IHW9272 CODI; GT2012 64720 IHW9001 SA 64723 IHW9002 MZ070782; Gt1060 64726 IHW9036 SP0010 64729 IHW9107 LKT3; GT321 64732 IHW9234 CRB; GT1183 64735 IHW9021 RSH; GT1083 64738 GT1099; GT1100 64741 GN100 64744 IHW9058 OMW; GT1061 66671 KATO III 73158 HLE_B3 73207 HOS TE85 73285 KUT-2 73321 Molt-4 73328 HCT-15 73354 MIY-3 73391 TE 6 73426 SF-HT (ATL cell line) 73436 P39 73481 AMS3 73579 SAJ022 73633 MRC-5 73670 human glioblastoma cell line, T98G 74263 QGP-1 74397 CGM1 74405 COLO 201 74646 AKIBA 74655 SH-SY5Y 74697 IMR-32 74911 NEC14 75000 embryonic carcinoma, NEC14 75019 KD 75125 TIG-1 75222 ACC-LC-170 75435 KPB-M15 75450 HepG2 liver tumor 75719 primary-cultured 75759 21 76016 ZR-75-30 76101 HUE4 76223 MCAS 76303 SK-MEL-28 76423 SMKT-R3 76439 KM-102 76447 MeWo 76677 NCC-MS-1 CDDP 76721 HIgMXL AO-EBV B 76734 KRO3 /4 (IHW 8w141) 76749 NTERA2-D1 76815 SK-RC-10 76881 Nalm-6 77013 HEK-293 77242 SV40 transformed MRC-5 fibroblasts (MRC-5 V2) 77256 Clara 77420 teratocarcinoma NTERA2 77497 fetal brain 77649 Yusiti 77699 myogenic cells 77717 daudi 77751 diploid fibroblast cell line VGS 77785 HEC-1B 77916 3D6. 78063 SH-SY5Y cells 78260 yusiti 78376 teratocarcinoma 78399 transformed human amnion cells (AMA) 78462 RF.BM, YF.PB2 78584 BC2 78589 BCBL1 78592 HBL6 78782 Therad 7 (59/19.59) 78788 therad 7 (59/19.59) 78795 Therad 10 (76/55.1) 78807 Therad 24 (174/102.21) 78919 LB129-SCLC and PBL 79041 530 79049 human malignant glioma cell line MO59J cell 79148 GTL-16 79547 518/IL2.14 79555 518/IL-2.14 79758 B lymphocyte 79771 CF Pac1 79778 GM5756T 80036 ZR75 breast cancer cell line 80254 Me18732 80496 MG63 ostosarcoma 80671 HCT 116 80677 LB33-MEL.A-1 (tumor cell line) 80811 T122.12 80854 T122.12 and peripheral blood monocyte 80873 PH63-14, PH63-15 80889 peripheral blood monocyte 81195 SP(3,4,18,24,27,42) 81199 SP(1,12,14,16,23,35) 81202 SP17 81205 SP25 81208 SP6 81211 SP20 81214 SP1 81217 SP43 81220 SP2 81225 SP8 81228 SP19 81232 SP(10,18,24,26,27,42) 81235 SP4 81239 SP(12,16,23,35) 81242 SP7 81399 SV-40 transformed 81484 WI38 81547 MV3 81685 HSC172 (16PDL) 82314 VH-64 82329 SW613-S 82403 colon carcinoma SW613-S 82444 Colo 320 82448 HDLM-2 82453 Karpas 299 82456 KM-H2 82459 L 1236 82462 L 428 82465 Tera II 83729 NK92 83906 YAR 83976 OZB 84004 Human hybridoma 84012 Epstein Barr Virus-transformed B cells and 84015 Epstein Barr-transformed B lymphocyte and 84020 HeLa Cell 84140 SW 480 84198 AGS and KatoIII 84205 adenocarcinoma cell line AGS 84305 human medullary thyroid 84364 3C 84372 ALBA 84386 HeLa (ATCC # CCL2) 84492 HOG 85031 ROHA, Hairy leukemia cell line 85254 weri 85467 Thyrocarcinoma cell line ATCC CRL1803 85577 pancreatic adenocarcinoma cell line HPAF 85612 leukemia cell line JuanaW 85745 Fetal lung 85750 Lymphoblastoid cell line, testis, fetal lung 85766 LB23-SAR 86748 adult T cell leukemia cell line JuanaW 86955 Reh 86984 IMR32 87034 mammary carcinoma, MDA MB 435 87042 Namalwa Burkitt lymphoma 87075 AMA cells 87209 HSC93 87279 CBGA1 87296 MacK 87347 LEP2E9 87420 MH6 87457 EBV-transformed cell line 87464 Heteromyeloma 87483 SV80 87545 medulloblastoma TE761 87555 TE671 87573 EpG2 87638 KB100 cyt1 87675 B5-589 87704 reticulocytes 87719 SPAZ 4 87763 HS74 87777 K562 and human T-lymphocytes 87824 Osa-Cl 88010 SKOV3 88064 SK-MEL-19 88090 FIS 88117 HepG2 hepatocarcinoma 88132 AH-2 88137 AH2 88626 CCRF-CEM/E1000 88656 myelocytic leukemia cell-line U937 88703 BO2C11 88939 IHKE-1 89220 AS30 89222 AS31 89225 AS32 89228 AS33 89230 AS34 89232 AS35 89235 AS36 89238 AS38, AS42, AS44 89240 AS39 89243 AS40 89245 AS41 89247 AS43 89249 LC37 89252 LC38 89255 LC39 89257 LC40 89385 AG 1518 human foreskin fibroblasts 89394 erythroleukemia (HEL) cells 89404 LS174T. 89440 RPM18866 89630 reticulocyte 89696 hepatocellular carcinoma (FOCUS) 89734 SKW6.4 89824 HT29-MTX 89838 glioblastoma ATCC HTB14 89888 SHSY-5Y 89945 ARM/BC11 (human-human hybridoma) 90007 transformed human amnion cell line (AMA) 90014 RPMI 8226 90124 ATL-2 (human HTLV-I transformed T cell line) 90165 Lx-1 90214 IMR32 human neuroblastoma 90228 HepG2 and MOLT-4 90360 DAUDI B*4102 90377 DAUDI B*5802 90450 FLEB14-14 and HL60 90491 HT29 colon carcinoma cell line 90505 Burkitt lymphoma Daudi 90522 ATL-2 90586 EBV transformed B-cell lymphoblastoid cell 90606 KBM-5 90639 hematopoietic 90735 Kato-III 90769 HIV/U937 90819 Burkitt's lymphoma cell line BL-29 90836 BL29 90846 BL31 90853 BL36 90860 BL41 90893 IARC-BL64 90903 Colon carcinoma cell line CaCO2 (ATTC HTB37) 90982 PA-1 90995 hybridoma derived from peripheral blood 91050 Brad-3 91126 3nbHPG 91151 non fractionated non cultures normal 91198 UD53 91205 BTII 102, BTII176, BTIII 1, BTIII 13, BTIV 54 91208 BTII 141 91211 BTII 158 91214 BTII 175, BTIII 44, BTIV 32 91218 BTII 180, BTIV 13 91221 BTII 36 91224 BTII 68 91227 BTIII 53 91230 BTIII 56 91233 BTIII 60 91236 BTIII 65 91239 BTIII 85, BTIV47 91242 BTIV 58 91490 rhabdomyosarcoma line A204 91494 CA46 91503 human medullary thyroid carcinoma cells hMTC 91511 hMTC cells (human medullary thyroid carcinoma 91518 CRL 1475 (ATCC) 91583 WI38 human fibroblast (ATCC) 91602 normal human duodenum 91820 E.Coli Y1090 91829 monocytes U937 (nt 1-917) 91849 NIH3T3 91874 IM-9 (ATCC CCL159) 91881 CB-201 92034 NSO transfectant 10B3 92039 human (fresh) thymocytes 92083 CLL leukemia 92155 HPBALL 92261 NK cells 92281 BJA-B Burkitt lymphoma B-cell line 92296 qm637 92327 EBV transformed Human peripheral lymphocyte 92355 DU145, human prostate carcinoma cell line 92359 LNCaP, human prostate carcinoma cell line 92387 PC3, human prostate carcinoma cell line 92433 Reh (ATCC #CRL 8286) 92438 synovial T-lymphocyte 92473 HT1080/Dr4 92621 HER XC2 (retina) 92735 EK 4 92800 human blood 92886 ML-2 92937 CRL 1106 92988 foetal lung fibroblast HFL-1, ATCC CCL153 92999 JIMM-69 93013 HT 1080 93088 A2058 melanoma 93304 RHEK-1 93362 NTERA2/D1 93429 MIA PaCa-2 93467 human Tera-2 (EC) 93485 CTL 102DRF 93489 CTL 172DRF 93493 CTL 17A2 93498 CTL 212DRD 93502 CTL 28 93506 CTL 40 93510 CTL 5A2 93514 CTL 64DRF 93519 CTL 64.8P 93523 CTL 67DRF 93533 CTL G36 93537 CTL GM7 93559 HeLa and testis 93570 B cell 93579 ANDP 93586 BM21 (1othIHW No.9043) 93592 CW698 93619 WI38 Human Fibroblast (ATCC) 93662 A-431 93721 FOB fetal osteoblasts 93822 IGR3 93934 DA3 93994 DAUDI 94079 721.180 94087 HUT-78, ATCC #TIB161 94102 normal adult and fetal brain 94129 human liver 94137 CGL 94169 Colon Carcinoma CaCo2 94288 AMA amniotic epithelial 94387 HeLa cervical carcinoma 94398 TT cells 94414 HeLa-cells 94426 liver 94471 HT29-D4 colon carcinoma 94660 thymic 94666 NALM-6 94684 UM-SSC-22A 94847 cytoplasmic extract from Raji (Burkitts 94855 HeLa, bone arrow 94944 THP1 95027 U937-B 95046 NF1032 95159 IARC-EW11 95203 caco-2 95238 peripheral blood leucocytes 95243 CCL186 95362 GM637 95389 human epidermal cylindroma 95396 MCF7 breast cancer 95418 human fetal muscle 95453 NT2/D1 95473 SK-ES-1 95479 ZR 75-1 95627 Caki-1 95680 COLO-16 95749 E.coli XL1-Blue 95768 hsc93 95837 Human PBL 95844 human PBL 95875 diploid dermal fibroblasts 95935 K937 95944 primary resting T-cells 96006 M432 96042 primary fibroblast culture 96234 Fog-1 96239 Fog-3 96245 Fog-B 96253 Fom-1 96259 Fom-A 96262 FOM-A 96322 KG-1, ML-1, MCF-7 96345 IARC 171 96501 Gad-2 96522 HEP G2. 96598 IMR 90 96652 WM266-4 96677 K 562, Meg 01, Jurkat 96701 E6SM (embryonic strain - skin and muscle) 96900 D-259 MG 97056 non fractionated non cultured normal 97065 human fetal liver 97140 Clones A,B,C,D,E,F + Line A.1-CD8 97191 PHA activated PBL 97226 KT30 97333 primary T-cell culture 97396 multidrug resistant Adr(R) MCF cells 97402 HEP G2 97459 glioblastoma 308 97533 HUT78 97572 L1 97579 D1 97600 uninduced teratocarcinoma 97606 HAM-B 97611 C32 97726 PLC/PRF/5 (Alexander cells) 97749 EW-1 Ewings sarcoma cells 97884 human epididymis tissue 97899 human-mouse hybridoma 97912 HeLa. 97941 HePTP 97968 purified high endothelial cells 97992 J6 and CEM 98063 transformed amnion cells (AMA) 98103 GMO3299 98166 KU-812-F 98242 KLO 98251 XLI 98272 K.LIE-EBV 98280 WT51 98296 SLUGEO 98328 lymphoblastoid cell line DCH013 98341 RML 98347 MAD61 98361 Kime 98368 Lymphoblastoid cells lines 98381 CR-B 98393 M54672 98410 GO85 98414 ENA 98418 MASCH 98422 CC 98427 25-1501 98431 MALS 98438 WWAI 98446 lymphoblastoid cell line DCH036 98454 GSW002 98460 Ci 98468 GB32 98474 SBD4 98488 GB92 98494 WM1361C 98501 LCL721 98511 B-lymphoblastoid, NDS-DG 98527 LE023 HLA phenotype A26,32; Cw1,-; B51,73; 98540 PAR HLA phenotype A11/24, B27 /48, DR11 /15, 98546 TAN 98567 bLcL(B-cell) 98571 OMW 98575 SH.JO 98579 3232 98593 2085(HLA-A1,29 Cw6sh,BL B52,61 DR14,15 DQ5,6) 98600 C073, HLA phenotype A2/29, Cw2 /Cw6.2, B44/51, 98607 2085 98612 2088 98619 CO47 98640 GB86 98665 GB002 98672 LUY (IHW 9070) 98682 GB2 98706 LG2 98713 TUBO 98732 MOLT-4, clone=M4-117 98751 LEO23 HLA phenotype A26,32; Cw1; B51,73; 98843 HeLa cell line 98857 RPMI4265 98864 DLD-1 98873 PLC/PRF/5 98906 MRC5 98966 ZR-75-1 (human breast carcinoma) 99072 SCLC-10 99079 Small Cell Lung Cancer-10 99123 peripheral blood mononuclear cells 99185 hepatoma G2, leukaemia Molt4 99297 CMD004AN 99326 HEP-G2 99335 A549, ATCC #CCL185 99342 ZR-75-1, ATCC CCL119 99382 NH17 99508 HT 1080 (fibrosarcoma, ATCC CCL 121) 99540 Wish cell 99551 HN.F1BB5 (human-human hybridoma) 99593 human hepatoma cell line,Hep G2,ATCC HB 8065 99626 NTERA2-1 99648 NTERA1-D1 99678 FS-4 99710 HEP G 2 99718 OVCA432 99804 Jurkat leukaemic T cell 99826 4251 astrocytoma 99852 HEL cell (Flow 2000) 99887 Total human foetal liver 99911 E.coli dM105 100038 CLL001 x HMMA 2.1 heterohybridoma 100045 CLL030 x HMMA 2.1 heterohybridoma 100050 CLL033 x HMMA 2.1 heterohybridoma 100056 CLL039 x HMMA 2.1 heterohybridoma 100059 peripheral blood B cells 100062 CLL040 x HMMA 2.1 heterohybridoma 100067 CLL055 x HMMA 2.1 heterohybridoma 100072 CLL057 x HMMA 2.1 heterohybridoma 100250 hybridoma ED8.4 100256 U266BL 100278 F1.1 100296 Farage 100324 WS8 100355 HepG2 Hepatoma cells 100371 G1.1 100378 human /mouse (NS-0) hetero-hybridoma cell line 100441 D10.E6 100445 B12.F8 100479 RSP-4 100483 RH 14 100488 T33-1 100491 T33-2 100494 T33-4 100496 T33-16 100499 T33-17 100502 T24-9 100505 T33-20 100520 hybridoma cell line: GAN4B.5 100527 EBV transformed B cell line R 149 100530 RSP-1 100535 GM 4672 100660 J2.2 100665 BL JBL2 100672 Ly66 100677 Ly91 100688 rescue fusion 1b11. 100691 rescue fusion 1h1. 100708 rescue fusion 2a12. 100711 rescue fusion 2c12. 100780 9F12 (ATCC no. MB 8177) 101082 human-mouse-heterohybridoma P61B27 101097 CLL B lymphocytes 101102 Epstein-Barr transformed lymphoblastoid cell 101181 HF_21/28 101198 Ly47 101223 rescue fusion k4h8. 101226 rescue fusion k5b8 101229 rescue fusion k5c7. 101232 rescue fusion k5g5 101235 rescue fusion k6f5 101238 rescue fusion k6h6. 101241 hybridoma LSF2 101247 4G12 101269 BL Ly47 101275 BL Ly91 101283 SSK41 101289 lymphoma 201 101313 hybridoma 101324 mAb 61 101328 Ab 63 101337 Nalm-1 101342 4G12 hybridoma 101396 hybridoma Ray 4 101482 RF-KL5 101488 RF-MR2 101493 RF-MR25 101496 RF-MR28 101499 RF-MR30 101502 RF-MR33 101505 RF-MR37 101508 RF-MR1 101514 RF-MR13 101517 RF-MR16 101520 RF-SJ5 101531 RF-TS7 101541 RF-MR14 101546 CM3.B6 101550 hybridoma SB1/D8 101553 hybridoma SB5/D6 101556 T1.1 101558 T34-1 101560 T20-24 101562 T20-11 101564 T21-9 101566 T23-9 101568 T24-3 101575 immunoglobulin phage display library 101655 CLL-12 101660 CLL-27 EBV 101666 LAZZ-21 101672 EBV-21 101846 GM2132 101920 EBV383 102093 CAKI-1 102115 NCIH69 102121 NCIH82 102135 THP.1 - acute monocytic leukemia 102147 CB233 102199 Namalwa 102234 YT 102241 TCL-Na1 102279 IM-9 102382 uninduced male teratocarcinoma, NT2 /D1 102440 FG 102449 HPB-MLT 102480 Primary explant, passage 4 to 10 102500 Jurkat-111 102508 Jurkat III 102756 M10 102774 NALL-1 102795 5583S 102820 CAPAN I 102862 Jac-10 102889 B-lymphoblast RPMI 8866 102919 JI 102923 JIJOYE 102936 AML,KG-1 103093 5583-S 103101 L540, YT, K562 103146 Molt 4 103183 Jurcat 103301 HOC-8 (ovarian carcinoma) 103316 UCLA-P3 103349 NTera-2 103374 U937 Lymphoma 103426 SSC25 103565 F55IIIE5 103633 human keratinocyte 103639 SCC25 103667 human placenta, human colon carcinome 103731 BeWo 103769 IB4 (human B cell, human tonsil) 103803 COLO201 104011 C10-MJ2 104077 LJ 1 104083 RPMI 4265 104156 AG1518 113221 Mad-2 113237 U937 PMA-stimulated 113256 human thymocytes 113277 NT9D1 113319 SKBR-3 113356 Burkitt lymphoma Daudi. 113382 Hep62 113389 MCF-7.2.2 113406 Hep-2 113416 U105MG 113475 A375met 113529 WM 1158 113535 SCLC-6 113550 ML3 (acute promyelocytic cells) 113575 MV3 melanoma 113597 GTL16 113605 Raji (Mer+) 113613 600 PEII 113648 melanoma HTZ19 113656 Hs294T melanoma 113676 Hela, IMR90 113689 MICA 1 113696 MICA 2 113702 MICA 3 113708 MICA 4 113714 MICA 5 113721 MICA 6 113727 MICA 7 113756 normal adult human epidermal melanocyte 113763 HeLa S3 ATCC CCL 2.2 113778 IM9 113804 primary human skeletal muscle culture 113868 THP-1 (ATCC TiB 202) 113875 JURKAT T CELL 113916 bone marrow 113994 HL-60 promyelocytic leukemia cells 114083 RPMI 8226 and U266 114091 PHA/PMA stimulated T cell 114125 PLC/PRF/5 (Alexander) 114305 Namalwa line NM864, NM878 114314 ATCC HTB 17 U-373 MG 114341 fetal lung cDNA 114375 human breast cancer cells 114452 IN 157 114507 EPG85-257RNOV 114601 HMP2 114923 Kelly. 114929 primary myoblast/myotube culture 114949 GLC 28, Kelly 115032 KM-3 115051 HELA 115087 cEM 115117 neutrophil granulocyte 115171 IMR 32 115200 NK 3.3 115212 NK B22 115333 MV1 115348 LS 180 115393 NTERA2 115398 LCL 115427 1.Hepatoma, 2.GM637 fibroblast, 3.HeLa 115489 Hs683 115551 U251 115589 Oak-3 115603 Raji cell line 115643 NTera2D1 115650 BJAB 115689 Og-31 115763 BJA-B 115809 HBL100/RAS1 116046 AKATA 116053 IARC/BL2 116055 IARC/BL30 116057 IARC/BL37 116059 IARC/BL41 116061 LOUCKES 116063 NAMALWA 116066 P3HR1 116068 RAJI 116070 RAMOS 116161 HBL100 116166 Pag-1 116199 HEP G2 hepatoma 116230 MCF-7ADR 116238 purified primary HEV endothelial cells 116284 ARMS282A 116297 Hut 78 116314 T15-42 116322 T33-5 116324 T33-14 116339 A9A2Br 116533 tera 2 /clone13 116539 U-2OS osteosarcoma cells 116564 Tera2 cl13 116706 EBV transformed cell line H2LCL typed 116713 EBV transformed lymphoblastoid B cell line 116795 1-gt11-library 116890 RT112 (bladder carcinoma) 116905 TF-1, KG1a 117030 nasopharyngeal carcinoma 117050 human peripheral lymphocytes 117106 A2058 (ATCC) 117117 hTera2D 117135 patient #22 cells 117138 patient #8 cells 117140 patient #30 cells 117142 patient #31 cells 117145 patient #13 cells 117149 patient #32 cells 117152 patient #28 cells 117226 Melanoma cell (Bowes) 117460 NTERA2-cloneD1 117543 Human 293S from Dr. B.Stillman (NY,USA) 117548 Human 293S from Dr. B.Stilliman (NY,USA) 117557 PDL 27 117659 foetal liver spleen 1NFLS 117713 MKN-45 117744 KG-1 (ATCC CCL 229) 117753 LE-9211RC 117818 T47D, mammary carcinoma 117837 T-cell leukemia JURKAT 117857 SK-BR-3 117901 breast cancer cell line SKBR-III 117985 EK4 118009 breast carcinoma ZR-75-1 118140 pheochromocytoma 118171 HeLa S3 (ATCC #CCL2.2) 118203 RAJI human lymphoma 118219 HL60 (1) 118325 NEC 118367 HeLa, CHP100 118377 EJ bladder carcinoma 118384 Ca. SW850 118392 Reg-A 118421 NTERA-2/D1. 118436 U937 and peripheral blood mononuclear 118619 11-50 118623 11050 118626 HMST-1 118648 CEM, U937 (gamma interferon induced) 118657 NBC 118715 HUT-78 118727 GLC28 118810 5637 118900 ewing 118907 WI-38 human lung fibroblast 118915 HL-60, Y-79 118937 Manca B 118954 B-LCL 118989 human lymphoid cell line 119025 CA2 119054 H2LCL 119157 NTERA-2 119181 Daudi Burkitt lymphoma cell line 119196 human thymus 119202 human thymus 3 year caucasian male 119256 Raji lymphoma 119342 HCT116 119409 AMA (transformed human anion cells) 119528 SW-1573/1R50b 119568 human periferal lymphocytes 119615 HT29-M6 119667 raji 119788 A 119820 tumor cell line U251-MG 119857 HEP-3B 119909 heterohybridoma 120145 lambda gt11 cDNA 120429 jurkat 120473 T47D breast tumour 120919 melanoma cell line SK29-MEL-1 120945 human placenta 121213 LT5-1 melanoma cell line / normal melanocytes 121249 foetal spinal cord RNA 121319 Raji: burkitt lymphoma cell line 121327 HepG2, liver tumor stimulated with IL-1 121342 Ishikawa 121371 adenocarcinoma cell line 121455 SW613-S clone 3 121493 ST486 121501 Human teratocarcinoma 121595 cancer cell line HT-29/M6 121687 HL60 cells 121696 KU812 121724 cultured foetal human lung fibroblast 122081 EBU transformed: T14 122086 EBU transformed;T14 122236 ALL-1 122333 DX3 122419 HA1.7 122427 DE49 122431 DH15 122593 T cell clone (TCC) 4:1.1 122596 T cell clone (TCC) 4:14.4 122599 T cell clone (TCC) 4:2.15 122602 T cell clone (TCC) 4:2.20 122608 T cell clone (TCC) 4:3.1 122611 T cell clone (TCC) 4:7.4 122682 Jurkat and HPB-ALL 122799 ALL1 122820 MANN 123249 PBL clone 25-244 123252 PBL clone 26-331 123264 PBL clone A96 123267 PBL clone 81-20 123275 PBL clone 82-1 123278 PBL clone 82-82 123283 DE26 123287 DD11 123290 DH12 123294 de5 123304 PBL clone 119 123308 TIL clone A21 123311 PBL clone A81 123320 TIL clone A36 123336 acute lymphocytic leukemia T cell line 123390 RB2 123502 DE5 123521 TIL clone A25 123581 IW6 123626 CL-1 123654 PEER 123779 MOLT13 leukemia 123909 T cell clone Mb11 124098 Tera-2 (EC) 124136 activated HUT78 cells 124143 RPM 4265 124148 A2243 synovial sarcoma 124182 preB cell 124213 SW613S c13 124227 A172 glioblastoma 124275 FOB-cells 124296 pituitary adenoma 124352 KB cell line 124392 GIN-1 124603 23.4 11+, HT-29. 124612 LOVO (ATCC CCl 229) 124854 HeLa and KB/6b 124948 22-12b (murine NIH3T3 cell line) transformed 124956 HT1080 and M426 124965 islet-specific T cell line 124996 LASTD teratocarcinoma 125017 Hela (nucleotides residues 1-200 only) 125024 human leukemia cell line 125088 T-cell clone LB117 125109 T-cell clone LB207 125113 T-cell clone LB210 125121 CII 125143 T-cell clone WM14 125150 tertiary tumor from transfected NIH3T3 cells 125156 transfected NIH 3T3 cell 125172 Daudi cell line 125189 MOLT17 125206 CII. 125284 NIH/MDA-2 125297 NIH 3T3, MDA-MB231 125657 NF861 125677 Human placenta 125746 human brain poly(A)+ RNA 125773 HT-1080 (ATCC CCL121) 125832 K422 125858 tumor material JN 125862 tumor material KD 125866 tumor material MM 125943 T-cell lymphoma PEER 125968 NTERA2D1 125999 S7 human melanoma cells 126068 BL979 126111 melanoma H3606 126120 293, Akata, Nalm-6, HeLa 126128 BL-29 126188 B5/589 126216 A-704 cells (ATCC HTB 45) 126230 Hs294T cells (ATCC HTB 140) 126241 RH30 126262 U188-MG 126271 Kcl22 126279 MRC-5 V2 126305 CMK 126326 K-562 human erythroleukemia 126368 GEE018 126410 mg63 126443 MG-63, osteosarcoma cell line 126459 PL-1 126473 M7 126510 HPB-ALL T cells 126568 MGAR (9014) 126575 W7079 126591 clone 22 (T cell) 126599 PP 126626 MonoMac 6 126645 GM6061B 126661 AMc 126679 cc102 126685 SHSY5Y 126691 CL170 126696 20015 126701 10243 126721 JY EBV B lymphoblastoid line 126769 colon carcinoma LIM 1215 126791 LK707 126799 SV48 thymic stroma 126882 SU-DHL-1 126988 Hep 3B 127006 M426 cells 127044 melanoma cell line, 501mel 127067 LUY 127076 H929 127113 WDV 127117 DO208915 127122 LK 127163 human x mouse heterohybridoma CA4 127170 RSH 127182 olga (9071) 127203 SAOS-2/B10 127224 Culture 10 127229 Culture 5 127283 CF/T43 127288 PHA Blast ST-EMO 127300 RSH 9021 127306 HSB2 127323 NTera2/D1 127712 Culture 5(Vb17+/Va2.3+) 127717 Culture 5(Vb17+/Va2.3-) 127758 CMK11-5 127765 CCRF-CEM acute lymphoblastic leukemia 127774 hepatoma G2 cell line 127842 ALL-1, KCL-22 127853 cell line IM-9, ATCC CCl159 127857 Dakiki 127861 Burkitt's lymphoma-derived cell line Davdi 127865 Human lymphoma-derived cell line MC116 (ATCC 127868 myeloma-derived cell line IM9 (ATCC CCL 159) 127872 lymphoma-derived cell line MC116 (ATCC CRL 127875 myeloma-derived cell line RPMI 8226 (ATCC CCL 127881 Jurkat T cell leukemia line 127942 YT (natural killer-like) 127948 PBL 128005 22-12b (human met-transformed NIH3T3 cell 128039 HeLa D98/AH-2 128180 LBF (LBUF, 10W9048) 128186 gingival fibroblast 128208 HRPE cell line #165 128221 ATCC CCL136 128234 CCRF-HSB2 (ATCC CCL 120.1) 128282 OsA-CL 128392 YT, HUT-78 128493 LB33-MELc1 128505 AP630 128511 BL41/B95-8 128652 DM150 128675 PA-1 human teratocarcinoma 128698 BJAB human B lymphocyte cell line cDNA 128750 A3.01 128838 B lymphoblastoid 128912 Gw144 128999 normal human peripheral blood-derived 129026 HL-60 neutrophils 129079 JC11 129103 HeLa, subclone D98/AH-2 129282 CEM T-cells 129453 BM14 129492 DD18 129502 DD2 129509 DD22 129513 DD30 129520 HD22 129527 HD40 129534 HD47 129543 HD51 129553 HD53 129560 HD54 129567 HD56 129574 HD59 129583 JC14 129587 JC16 129594 JC18 129601 JC2 129609 JC3 129614 JC5 129620 JC9 129626 JD22 129633 JD5 129637 MC13 129644 MC14 129653 MC19 129660 MC36 129667 MD28 129674 MD30 129680 MD31 129686 MD32 129693 SC2 129700 SC24 129706 SC28 129716 SC3 129721 SC30 129727 SC31 129733 SC32 129739 SC33 129746 SC34 129751 SD15 129758 SD19 129762 SD21 129823 IMTLH 129858 PC-3 prostate carcinoma 129922 megakaryoblastic cell line M07e 129946 human keratinocyte cell line SCC 12-F: 130006 GM5424 130011 GM0435 130080 peripheral blood 130106 Y-79 retinoblastoma 130341 EBV transformed B lymphoblastoid 130422 MOLT4 130517 GN032 130520 GN037,GN041 130523 GN033 130596 ODM-2SV40 130610 A8496 130659 interferon-treated U cells 130700 HC10 130898 AMALA 130943 MZ2-MEL.43 130979 ATCC TERA-1 131031 ASKMN 131077 K562 erythroleukemia 131099 K562.4CF 131117 H441 131123 ZR-75-1 (ATCC#CRL 1500) 131133 888 mel 131155 mAb 10.2.3 131169 lymphoblastoid JY cell line 131252 Jurkat T-cell leukemia line 131269 U118-MG 131338 BL29 Burkitt's lymphoma 131385 LB33-MEL.A-1 131532 CF 131536 BPot 131679 osteoblast primary culture 131756 BT-20 breast cancer cell line 131762 K562 leukemia cell line; HEL leukemia cell 131791 Hep3B 131803 Hela cervical carcinoma 131854 U-937 histiocytic lymphoma 131908 A10 131989 NK3.3 132025 Hep 3B hepatocellular carcinoma 132071 Hela D98 132083 EBV-transformed lymphoblastoid cell line 132128 DMS-79 small cell lung cancer line 132177 HeLa S3, exponentially growing, ATCC #CCL 2.2 132206 SCC83-01-82 132466 breast cancer cell line ZR75-1 132514 TT 132586 2E9 anti-cryptococcal monoclonal antibody 132591 3B6 anti-cryptococcal monoclonal antibody 132730 EBV-transformed cell line DH 132749 THP-1, an acute monocitic human cell-line 132782 ST90-375 132784 ST93-724 132859 HL-60 promyelocytic cell line 132934 HeLa S3 cells; grown to semi-confluency 132990 RD105 and RD105U 132995 RD105 133028 Ad-312/SV40 cell line established from primary 133031 Li-538/SV40 lipoma cell line 133035 LM-30.1/SV40 leiomyoma derived cell line 133039 Li-14/SV40 lipoma derived cell line 133092 SKBR3 and ZR-75-1 133099 TE85 133106 143,2 133116 myeloma, U266 133176 YUSITI 133289 T84 cell line 133517 acute promyelocytic leukemia HL60 133540 HT-29 carcinoma 133598 MGR-1 133614 EBV transfected cell line RB22 133648 melanoma 530 133761 WI-26 VA4 133804 gn045 133825 hepetoblastoma HepG2 133862 RJ2.2.5 133872 CLL 1.19 133877 CLL 1.32 133889 CLL 1.69 133893 CTM 8958127 133945 hela cells 134047 Mz-ChA-1 cholangiocarcinoma cell line derived 134115 SMS-KAN 134207 GN097 134226 LA1-5S 134232 HUT-78 T cell library 134435 SW480, SW1463, SW1417, SW837, SW948, SW620, 134545 HeLa S3, exponentially growing, ATCC# CCL 2.2 134568 non-small cell lung carcinoma cell line 134687 acute promyelocytic leukemia NB4 134862 Lopez (NK cell leukemia) 134946 EBC transformed cell line LIE 135019 EBV-infected cell line: ML108 135029 TC-206 135036 Raji Burkitt's lymphoma 135164 HeLa cell subclone D98/AH2 135355 EC8712 135530 T-cell line Jurkat 135606 EBV transformed B cell line G1 135677 FM454 135711 MAME 135715 CTL 11DCJ 135717 CTL 12DCJ 135719 CTL 15DLH 135721 CTL 13DCJ, CTL 31DCJ 135723 CTL 18DLH 135725 CTL 23GLM 135729 CTL 28DLH 135731 CTL 49GCP, CTL54GCP 135733 CTL 36DLH 135735 CTL 37DCJ 135737 CTL 39GLM 135739 CTL 3.8DLH 135741 CTL 42GCP 135743 CTL 42.8GLM, 71GCP 135745 CTL 43DCJ 135747 CTL 5DLL 135749 CTL 48GLM 135751 CTL 56GLM 135754 CTL 5DCJ 135757 CTL 62GCP, 63GLM 135759 CTL 70DCI 135761 CTL 81DCJ 135763 CTL 74GCP 135765 CTL 77GCP 135769 CTL 7DCI 135772 CTL 81GCP 135777 CTL 26GCP 135779 CTL 29GCP, 54GCP 135792 CTL 42.8GLM, 71GCP, 74.8GCP 135801 CTL 62GCP, CTL 63GLM 135903 lymphoblastoid; normal diploid fibroblast 135912 NCI-H441 lung adenocarcinoma 135958 SV-80: human fibroblastic cell-line 136020 KB, HeLa, OVCAR-3 136046 LB96-SAR 136075 Jurkat T-cell line 136089 BEN cell line, Moseley, J.M. et al. (1987), 136191 EBV transfected cell line AA859 136196 MCF-7 human breast cancer cell line 136210 HT1080 fibrosarcoma 136235 EBV transformed cell line TC106 136243 EBV transformed cell line, TC106 136285 OsA-Cl 136339 MDA-MB-468 mammary epithelial carcinoma 136346 MDA-MB-468 mammary epithelial carcinoma cells 136503 hybridoma Ann23 136546 human glioma cell line G61 136552 megakaryocyte lines CMK11-5 and DAMI 136635 Jurkat T cell line 136641 Jurkat T 136681 Hela S3, exponentially growing (ATCC# CCL2.2) 136685 Jurkat T-cell line, ATCC E6-1 136704 neo6/C8161.1 136768 heterohybridoma:46E7 136772 heterohybridoma:43f10 136775 heterohybridoma:28e4 136778 heterohybridoma:26c1 136781 heterohybridoma:25f5 136784 heterohybridoma:24a5 136787 heterohybridoma:21h9 136790 heterohybridoma:19a5 136793 heterohybridoma:13e10 136796 heterohybridoma:13d2 136799 heterohybridoma:46e7 136871 breast cancer cell line 136888 ALL cell line HB11;19 136989 Jurkatt T cell line 136995 B6B7 137019 Jurkat leukemic T cell line 137073 EBV transfected cell line ML108 137286 EBV transformed B-cell line GN090 137304 Daudi and CCRF-CEM 137378 peripheral blood T cell line stimulated by 137442 MT-2, HTLV-1-infected lymphoid cell line 137456 breast carcinoma cell line ZR-75-1 (ATCC CRL 137516 SH-EP1 neuroblastoma cell line 137587 HeLa, RL95 137893 mammary tumor (ductal carcinoma) cell line: 137910 MCF-7 human mammary 137923 CaCo-2 138231 mammary epithelial cancer cell line MCF-7 138261 Chromosome 6 Suppressed Melanoma Cell Line 138273 SCLC line MM-1 138300 mammary epithelial cancer MCF-7 138366 W652D, Epstein-Barr transformed 138388 leukemia cell line HL60 138507 normal human primary keratinocyte culture 138539 choriocarcinoma cell line, JAR 138571 SKH1 138669 lung adenocarcinoma A549 stably transfected 138725 oral cancer cell lines SCC15, SCC25.Hu 138984 HeLa cell R19 138996 CEM human T cell 139033 B-lymphoblastoid cell line AZH 139066 CAL44 cervix uteri carcinoma cell line 139072 RPMI 8392 B lymphoblastoid 139102 EBV-cell lines ML108 and ML108U 139181 MDA-MB-231 breast carcinoma cell line 139217 megakaryocytic cell line MO7e 139272 ML108; ML108U 139311 CEM cells 139401 HAL-01; B-cell progenitor cell line 139472 hepatoma HepG2 139577 astrocytoma cell line 139676 CHRF288-11 139698 Jurkat E6 cells 139708 teratocarcinoma NTera2D1 cell line 139712 THP-1 cells 140048 glioblastoma cell line 140150 adenocarcinoma Caco-2 140167 232132/87 from gastric cancer 140255 MGR3 140310 21PT 140336 370 glyoma 140417 osteosarcoma cell line 140433 GN015 140457 HEpG2; HUVEC 140489 Epstein-Barr transformed B-cell 140553 MCF7; ATCC HTB22 140759 EBV transformed B cell line 19662 140801 LB33-MEL.A 141382 Louckes 141539 U118 glioblastoma 141583 H146 141628 OVCAR-3 141654 WI-38; K562 141795 A70 141799 437.3 141803 EBV transformed cells 141864 PCI-O6A 142069 MCF-7 breast cancer cell line 142180 G292 142266 PHA-PBL 142363 pancreatic cancer cell line Patu8988t 142385 HT-29 and Caco-2 142468 EBV cell line WAI047 142702 Patu8988s 142718 amelanotic melanoma; LOX 143014 LIM 1863 143193 cisplatin resistant cell A2780 E(80) derived 143199 cisplatin resistant cell line A2780 E(80) 143303 KLE 143322 Epstein-Barr virus-transformed B-cell LAZ-388 143585 Manca B cell lymphoma 143641 LIM1215 143658 t(15;17) acute promyelocytic leukemia NB4 143902 Namalwa B 144294 EB virus-transformed human B cell line 144413 CD34+ 144536 C1R 144546 Raji; B cell line 144616 Epstein-Barr transformed cell line 144700 T-cell 144850 breast carcinoma line MDAMB435 144872 EBV transformed B cell line 144990 T antigen-transformed diploid fibroblast 145028 MCF7 human breast carcinoma cell line 145139 DM0 145144 DM1 145149 DMId3 145152 DMId5 145296 MBW1 145345 NCI-H322 145475 C8161 145593 U87 MG 145664 leukemia H9 147036 BON 147326 L55 147392 T98G 147432 U937 histiocytic cell line 147800 EBV-transformed Korean B-cell line CH 147807 EBV-transformed Korean B-cell line KT 147813 EBV-transformed Korean B-cell line JS 147838 hybridoma 1C9 147913 immortalized first trimester human trophoblast 147919 monoclonal cell line 3.B6 147924 monoclonal cell line 1.H9 147926 monoclonal cell line 1.C8 147931 monoclonal cell line 5.G3 147935 monoclonal cell line 10.2.5 148028 PaTu8988t 148153 primary human foreskin keratinocytes 148160 primary foreskin keratinocytes cell line 148229 MKN45 (gastric) 148247 haemopoetic 148257 UK4 148301 HEC-1-B (ATCC) 148317 NIH3T3 cells transformed by human DNA 148394 P54 148442 medullary thyroid carcinoma 148524 LCLC97 148563 AB12 148596 AIDS-KS 3 cells 148603 PC-3 (ATCC CRL 1435) 148736 EBV 148874 HS 766T 148879 BL2 149015 Ab 60 149021 Ab 61 149028 Ab 65 149033 Ab 67 149041 genomic DNA 149058 peripheral blood from CLL patient P2 149062 peripheral blood from CLL patient P28 149065 peripheral blood from CLL patient P29 149068 peripheral blood from CLL patient P30 149071 peripheral blood from CLL patient P32 149074 peripheral blood from CLL patient P34 149077 peripheral blood from CLL patient P4 149081 peripheral blood from CLL patient P46 149084 peripheral blood from CLL patient P48 149087 peripheral blood from CLL patient P53 149090 peripheral blood from CLL patient P7 149131 HT29-18C(1) 149211 fetal bone marrow 149223 E29.1 149425 ME180 149633 uninduced male teratocarcinoma cell line 149702 GM6061B lymphoblast cell line 149798 Raji, Mann 149882 PATU 8988s 149971 PATU 8988s (pancreatic adenocarcinoma) 150079 Patu 8988s 150328 NDS-JD 150412 KT30 (CD4+ T cell line) 150436 Lymphoblastoid 150466 MG63 (osteosarcoma) 150544 ZR-75-1; breast cancer cell line 150739 LB831-BLC 151028 RT6 hybridoma 151819 ROF-NL 151837 MG63, HL60 151869 HelaS3 151913 K562 erythroleukemic 151937 serum starved CEM 151971 T-cell lymphoma (PEER) 152019 123AV16-1 152275 GM 639 152491 RD(CCL 136 human embryonal rhabdomyosarcoma ) 152591 neuroblastoma IMR32 152600 HT29-18 152632 0041 (M. Del Monte) 152713 chronic myelogenous leukemia cell line EM2 152731 simian virus 80 transformed fibroblast cell 152736 chronic myelogenous leukemia cell line K562 152760 SW 1116 152782 BEN 152823 HeLa (D98/AH-2) 152896 MG-63 152914 THP-1 (Phorbol ester activated) 153092 HH-16 153167 HuH-7 153187 AGS 153257 HT144 153262 HT-144 153443 UMSCC2 153582 Kasumi-1 153602 SK-Mel-28 153610 SK-Mel-28 (ATCC HTB 72) 153708 hepatoma G2 153778 human glioma explant HS 683 (ATCC # HTB 138) 153889 HMMA2.11TG/0 153967 YN-1-0-A 154119 Li7 154315 breast cancer cell line MDA-MB 231 154333 ags 154353 HepG2 cells 154598 ATL-16T 154606 intestinal mucosa teratocarcinoma cell line 154678 HEPG2 154769 A2058; established from brain metastasis 154784 B5.65 154976 Namalwa and UOC-B1 155054 ATCC A253 155159 GM06141A 155214 promonocytic cell line U937 155312 23.411+ genomic transfectant 155317 delta 6 from MIA PaCa (ATCC CRL 1420); B3-3 155344 CCD-16Lu 155417 NCI-N417 155443 cultured human keratinocytes 155462 Osteosarcoma cell line, MS 155531 BJA 155539 KATO-III 155577 Hela cells 155595 E. coli DH5 (pjptHUMB) 155609 HT-H 155617 K562 human erythroleukemia 155687 placenta cDNA 155813 of S.L.C.Woo 155902 C-Li21 156110 184N 156147 BIN-67 156191 43D-Cl2 156338 AGS 1-6-30-1 156361 W38 and U2-OS 156403 hep G2 156419 differentiated HL60 156547 con A induced PBL 156556 HUT-102 156575 K562/ADM 156634 JY + DAUDI 156642 promyelocytic tumor cell line HL60 156717 U118 156763 TIG3 156894 pBluescript 157017 melanoma SK-Mel-28 157048 LS174T 157201 HPBL MLTC(-) 157287 glioblastoma 157427 hepatocellular carcinoma; FOCUS 157704 86-226 157917 erythroleukemic K562 158322 Li21 158422 Human glioblastoma U118 158427 Jujkat 159911 KB cell 160105 ATCC TIB 161 160380 B6.6 160385 HL60R 160393 EBV-transformed peripheral blood lymphocytes 160475 HuH-6 160489 Nalm 6 160578 ACHN 160598 HeLa and keratinocyte 160605 mononuclear cord blood cells stimulated with 160717 CHP100 160801 L428 160808 HEC 160889 COLO 320 160903 K562 human erythro leukemia cell line 160922 LX-1 161000 neuroblastoma IMR-32 161091 HEL; MLT; Daudi 161106 Chang liver 161164 cervical cancer cell line cc-7T 161190 JURKAT 161264 HTB119 161392 RH 161422 unfractionated non-cultured keratinocyte 161454 A204 161557 U1242MG 161783 D65MG 161807 CML K562 162197 PHA/PMA stimulated Jurkat cells 162412 Li-7 162438 K562 cell line 162451 SW948 162502 GaCa 162578 Ht-1080 162690 RD-ES-1, A2095 162710 Hut78 162737 FS-2 163092 AC5 163183 xenograft D245MG 163218 HGT-1 163250 G2 163365 TC79-842 163446 M-07 163458 BeWo choriocarcinoma 163829 NCI-H345 163952 ZR-75-1 0) 164044 3B6 164225 human erythroleukemic (Hel) cells 164349 HEL 92.1.7 164358 KU-812F 164383 HeLa and HPB-ALL 164391 LK63 164427 A631 164492 RL95-2 164759 EBV Transformed B Cell line, B*5401 cDNA 164764 EBV TransformeVEN is an EBV Transformed B Cell 164769 EBV TransformeAPA is an EBV Transformed B Cell 164778 ENA is an EBV Transformed B Cell line, B*5602 164798 homozygous typing cell line SA 164800 homozygous typing cell lines MADURA, AMAI 164807 KT14 164826 MIY-1 164837 BH, VH, GTI3, GTI4 164859 HGOM 164871 JAP-NF 164879 NV 164885 35020 164890 MIY-2 164942 KAS116(9003), EMJ(9097), KAS011(9009) and 164946 EK(9054) 164949 AK93007 164952 MOU(9050), BOLETH(9031) and YT 164955 DKB(9075) 164958 SPACH(9072) and LUY(9070) 164961 VAVY(9023), BM16(9038) and AMALA(9064) 165028 HERLUFF 165047 QGP-1NL 165059 B-LCL CODI 165065 human monocyte 165195 TIG-3 165204 Namalva 165289 PER-225 165390 HPBL3x 165400 hystiocytic lymphoma monocyte-like cell line 165463 DOND 165469 KK 165474 GM6804 (Human Mutant Cell Repository, Camden 165639 EBV transformed B-cell 165666 WiDr; CRL 1262 165719 HT-1376 165740 gamma-interferon-induced HeLa 165929 SUP T1 lymphoblast 165943 U-373MG 166011 MG-63 osteosarcoma, (ATCC CRL 1427) 166108 SV40-transformed cell line MRC-5 166147 CTL/NK cell 166272 FS4 166410 T61 transplantable braet tumor 166434 HCV-3 166438 HCV-63 166441 HCV-65 166444 HCV-2 166477 hybridoma cell line, mAb-57 166519 265-695 166521 MD3-4 166523 OST577 166525 ZM1-1 166530 Human-mouse trioma cell line 166753 CB33 166774 BH1 166819 L612 EBV transformed B cell 166846 hybridoma 87-2 166938 417.32F4.8.5 166942 416.F2.2.34 166944 417.F25 166947 417.F21.5 166949 417.F14 166952 417.F22 166955 417.F1.1.35 166957 417.F23 166959 417.7.3.1 166961 417.F29 166963 417.32.F24.7 166966 417.F33.3 166968 417.F32.36 166970 417.F32.26 166972 417.F28 166974 417.F9.5 167010 LSH6 167052 9702 167055 B8801 167111 Kim4.6 167119 F3b6 mouse x human 167125 MO30 167131 9604 167134 B122-2 167136 B6204 167140 B8807 167142 B8815 167144 C119 167146 C471 167151 L2B5 167154 L2B8 167157 L2BS1 167160 L2D10 167163 L2E7 167165 L3G11 167168 s4D5 167170 s5A10 167189 s5D11 167191 s5D4 167194 s6A8 167196 s6C8 167198 s6E11 167201 s6H12 167203 s6H7 167205 s6H9 167319 SSH23 167374 lymphoblastoma 167439 MO58 167442 MO53 167445 MO81 167448 MO61 167556 16M3C8 167562 Hib JB32 167565 RC3 167576 HAF10 human-mouse heterohybridoma 167582 LBR 295 167588 LBR 962 167591 LBR 1045 167593 LBR 1189 167596 PHB 1213 167601 KES 643 167607 LBR 150 167610 LBR 271 167613 LBR 1104 167619 MRE 148 167625 hybridoma M7B5 167629 hybridoma T15G1 167660 NG9/9.1 hybridoma 167668 human-mouse trioma cell line 167801 RPMI 6410 167839 2E7 167843 hybridoma RC3 167852 hybridoma ED6.1 167856 lymphoblastoid cell line 167860 9500 167913 L2B10 167916 L2E5 167919 L2E8 167922 L2F10 167925 L2H7 167928 L3A10 167935 L3B2 167938 L3B6 167941 L3G5 167944 L2A12 168011 L612 EBV transformed B-cell 168018 EBV-transformed B cell 168049 B3 168114 lymphocyte 168132 hybridoma JB21 168135 hybridoma RAY4 168140 hybridoma JB32 168143 hybridoma 16M3C8 168210 BM-16 168217 Dauidi 168222 F4 168224 MB-19 168291 BM-18 168300 Ann2 168308 B20 168313 B9601 168317 MF8 168323 C304 168336 s5A9 168340 s5B7 168343 s6A3 168346 s6BG8 168349 s6C9 168352 s6G4 168380 8B3 168385 37GRK 168417 EBV-transformed 168421 418.F63.35 168451 316 168454 E51 168456 BD10 168467 4B4 168470 ITC88 168865 B21 168965 homopoietic TF-1 169105 032891 169113 Tera-2, U937, HL-60 169126 TE-89 osteosarcoma 169181 J5 169245 F6-2 169253 peripheral blood T cell 169269 JM101 169376 S3 (ATTC) 169381 Hela S3 (ATTC) 169418 A-172 169446 341-72 169473 BS2 169644 T CELL 169845 DT 169873 Nt2D1 169895 NCC-IT 169968 Kelly 169974 H3347 169980 RSA-ND 169987 acute promyelocytic leukemia cell lines HL-60 170016 keratinocytes 170084 IMR-90 leukemic 170297 LH114 170304 LH92 170344 MP-1 170452 DU145, LNCaP, PC3 170583 SP-49 170599 RPMI 1788 170608 T cell hybridoma (AC5-8) 170636 Daudi/Molt4 170662 SUP-T8 170679 HL-60 3c5I 170703 II-23.D7 cells stimulated with PMA for 4 hr 170753 mAb105 producing hybridoma cell 170757 mAb107 producing hybridoma cell 170776 mAb52 producing hybridoma cell 170780 mAb53 producing hybridoma cell 170784 mAb55 producing hybridoma cell 170788 mAb56 producing hybridoma cell 170792 mAb57 producing hybridoma cell 170796 mAb58 producing hybridoma cell 170800 mAb59 producing hybridoma cell 170954 WI26 VA4 170973 M73 170985 RPMI1788(EB virus-transformed B-cell line) 170997 HS913T 171005 184 (from M. Stampfer) 171107 Manca 171202 ML-1; U-931 171242 Mia-PaCA-2 171249 CEM-ON 171328 acute promyelocytic cell (ML3) 171370 U1-Mel 171399 retinal pigment epithelium (0041 from M. Del 171427 Human Lopez natural killer cell leukemia 171560 GM03560 171608 RC654. EBV transformed 171616 B lymphoblastoid HPB-MLT 171624 KRC033 171630 SHJO; 32/37; KRC032 171636 Bristol 8 171640 GRC138 171645 GRC138; JY 171659 AP630 EBV-transformed B cell line 171674 RSA (EBV transformed B cell line) 171678 CALOGERO (#9084) 171695 EBV transformed KY 171719 MLH (EBV transformed B cell line) 171722 KRC103 171726 EVB transformed B cell line 171730 krc103 171737 GRC212 171780 EBV-transformed LCL 171839 19148 171885 Epstein-Barr transformed B cell line DBB 171903 Epstein-Barr virus transformed lymphoblastoid 171927 373 171936 Hmy2 and C1R 171941 AP 171946 LWAGS 171949 2627 American Indian Tribe 171956 DAN723 171961 LEE743 171979 IMR-90, U373 (in part) 171988 IFN-gamma-induced U937 171995 THAI742 172023 GRC 150 172027 KRC 110 172067 LLICRF 172081 HLA-homozygous B 172088 VAVY, RSH,BH, DBB 172110 2012 172116 KAS116 172120 EMJ 172123 KAS011 172126 E418 1324 172129 Ek 172132 MOU 172135 BOLETH 172138 DKB, YT 172141 SPACH 172144 VAVY 172147 BM16 172194 DkB 172209 AMAI 172242 Vavy 172248 EK 172253 E4181324 172256 BH 172269 2013 172300 2708 172342 HMy2.A3m 172367 HMy2.DRN 172454 DR4 172516 1125 172521 AMALA(10w9064) 172524 CB6B(10w9064) 172546 EBC transformed B cell line SS713 172564 EBV-transformed 3104 B cell line 172586 RPMI 8402 172642 T-CEMB 172758 SP-49, KOCL-33, KOCL-45 172766 RS4;11 172796 U937/Dyl 172815 PMN 172821 MO6 172827 HL 60 172872 HPC-Y5 172906 MDA-MB-468 173128 BT20 173168 TIG-1-20 173189 stratagene E. coli XL1-blue 173198 IFN-alpha-2 treated cell line T98G 173221 COLO320 173234 promyelocytic leukemia cell line HL60 173239 promyelocytic leukemia cell line HL-60 173252 IFIO-D3 173523 HLC-1 173594 rhabdomyosarcoma 173657 VA13 173683 Nalm6 pre-B cell and RIC2 retinal cell 173690 MCH 200.3 173780 WI26-VA4 173787 namalwa 173796 A875 173827 jurkat T-lymphocytes 173938 B22 173946 PCR IM9 lymphocyte 173955 EBV-transformed B cell line RPMI 8866 174081 U937, cAMP induced 174201 GLC-1 174213 BS6 174243 U 174307 TYKnuR 174337 Jurkai 175016 platelet 175029 human breast carcinoma MCF-7; human lung 175100 H647 175114 HL60 (promyelocytic leukemia cell) 175265 EoL-1 (butyrate-stimulated) 175345 Capan-2 175352 HPAF-CD11 175428 CAKI-2 175442 Jurkat/Swei 175457 - 175664 AG 1518 175679 SK5 175694 Tera 2 175828 YTN-10 175978 blood platelet cell line HEL 176139 leukemia K562 176375 HuT-14 177031 NK3.3, natural killer-like cell line 177091 IM-9-P derived from IM-9 177130 AMA 177227 HEp-2 177327 MGC 1 177503 LNCaP-ATCC 177668 Daudi Burkitt's lymphoma cell line 177722 KU812E 177792 Meg-01, human platelets 177877 G401 178034 EBV-immortalized peripheral B-lymphocyte 178042 EBV-transformed peripheral B-cell line and 178068 SK-Hep-1 178177 retinoblastoma cell line Y79, and normal 178187 SCLC-SA 178197 BOY 178206 NALM 6 178233 G-401 (ATCC CRL 1441) 178305 0041 178314 NF1002 178404 A101D 178460 PA-1, teratocarcinoma 178489 D98/AH-2 178934 OXEN 179223 Eahy926 and HUVEC 179258 SW620 179264 HT29 cl-CIII 179346 HL1011B 179470 CCF-STTG1 179543 FLEB14-14 179776 human erytholeukemia (HEL) 179894 AML-193 179901 HPB-ALL ; CEM 180009 FS11 180054 Molt13 180196 T98G, CCF-STTG1, U87MG 180280 HOB1/VCR1.0 180296 manca 180344 5C10 180365 HUVE 180526 KB cells 180561 human hepatoma cell line KYN-1 180585 CCRF-HSB-2 180606 MOLT-4 cl. 8 180619 EBV transformed 180622 EBV transformed cell line 180627 LBUF 180638 Hut-78 180707 MOLT 4 clone 8 180713 LG37 180727 Tcc UA-S2 180955 JM 181484 TcHST2 181513 neutrophyl 181544 102DRF, 139DRD AND 2DLE (CTL CLONES) 181562 CTL 2DLE 181569 CTL 21S69 181571 CTL 27S69 181573 CTL 29S15 181575 CTL 2SRZ 181579 CTL 31GRK 181581 CTL 33.8S15 181583 CTL 33S69 181585 CTL 3SRF 181587 CTL 47S69 181591 CTL 58GRK 181593 CTL 74GRK 181595 CTL 74GRKB 181597 CTL 7S15 181599 CTL 93S15 181603 CTL 116.8GRK 181780 CTL 139DRD 181809 CTL 22DAG 181846 CTL 140 181898 AL4.1 181904 CTL 122GRK 181909 CTL 100GRK 181912 CTL 11.8SLG 181915 CTL 11SRY, CTL 40SRY 181930 CTLs 12SRF, 12SLG, 60SLG, 4S15, 11S15, 37SLG 181932 CTL 13SLG 181957 CTL 13SRC 181960 CTL 20.8GRK 181979 CTL 168DRF 181986 CTL 29s15 182057 CTL 58GRK, CTL 20.8 GRK 182064 GM2.11 182070 CTL 116GRK 182073 CTL 11SRY 182081 CTL 12SRF 182167 D38 182344 DS6 182356 KT2 182662 short ragweed pollen allergen-specific T-cell 182680 TcSSTW 183032 AL61.102 183103 W138 183141 Tera-2 183317 1027 F57 183703 UC/HeLa2-5 183774 HepG2, HeLa 183862 SPL 183975 GF-D8 184167 HMV-II melanoma 184173 A2058 184294 YT2C2 184332 M28 somatic cell hybrid 184352 MeWo melanoma DNA, and cDNA to mRNA 184384 U-105MG 184576 ECV-304 184623 HSB-2 184638 VS C64.03 184647 4-1D4 184654 46JVM-A11 184661 AY29 184668 14MT-B3 184673 VS F41.03 184679 14MT-C5 184690 46JVM-A1 184696 341-44 184712 14MT-D1 184726 B5.62 184736 AY51 184743 4-1A7 184749 AY7 184754 VS F55.03 184764 4-1A8 184768 AY28 184797 5E1 185096 CRL-1262 185146 IMR91 and CF150-6 185154 IMR90 185414 lymphoblastoid transformed cell line 188386 M426, WI38 189825 TC106 EBV transformed B cell line 189856 GM3299; GM637 189915 3T3-VMCUB2-1 190218 CEM C7 190258 A375 191328 Ble 193220 TTC466 193224 TTC633 193779 i37-4 193830 MC4100E3 193849 TIL A42 193905 RPMI1788 194007 pre-acute lymphocytic leukemia (pre-ALP) 194040 Jurkat J6 194237 CB STL-1 hybridoma 194341 hybridoma AEE111F 194651 RF1; RF48 196540 adenovirus transformed retinal cells, Nalm-6 196565 Bjab 196849 differentiated HL-60 cell 196861 T cell clone 196874 T cell line 196906 b cell clone 197010 NCI-H157 NCI-H889 197014 NCI-H157 197074 HeLa S3 cell line 197136 FCCM-9 197146 EBV-transformed Korean B-cell line (K-KT) 201647 NCI-H69 217350 AsPC-1(ATCC:CRL-1682) 226139 BT-325 328073 4AF1/106/KO15 602996 skov 603034 AP20 melanoma 603067 promyelocytic HL60 cell line 603385 HBE-M 603417 AGZY-83a 603509 A549.A549 603517 HSG 603824 HT1080-6TGc5 603927 LNCaP prostate cancer 603931 E8CASS; variant of MCF7 604617 OCI LY8-C3P; clonally related variant of 604643 HNE1 604671 u937 604693 normalized K562 605008 oc3-VGH 605084 PC-3M high metastasis subline 1E8 605088 PC-3M low metastasis subline 2B4 605118 PC-3M subline IE8 605154 PANC1 605171 SKOV3; 3AO 605273 BEAS-2B 605318 EB1 606062 HNE-1 606110 CGL3 606125 ATCC SW1088 606143 ATCC HTB-12; SW1088 606177 LoVo 608722 SGC-7901 942112 PMA-induced HL60 human leukemic cell line 1088530 T84 carcinoma cell line 1272416 Primary Culture of Peripheral Blood 1663273 Q1Z 1663586 HTori-3, control line 1663589 HTG9 1663592 HTG8 1663600 HTG13 1663610 HTA4 1663634 HTG2 1663648 HTLV-1 transformed T cell line C91-PL 1663662 HTLV-1 positive adult T-cell leukemia cell 1663690 adult T-cell leukemia cell line JuanaW 1663769 adult T-cell leukemia cell line JuaW 1707441 HeLa cell line; ATCC 1815757 THP-1 (TIB-202) 1816989 KB(ATCC CCL-17) 1818399 SK-Mel-28(ATCC HTB 72) 1958303 KG1-a 2029555 MGC3 2065539 melanoma microcell hybrid line, MelJuSo-28(1n 2065542 melanoma line, MelJuSo 2094290 MGC2 2095027 MGC4 2095899 MGC1 2142162 MGC85 2273300 MGC36 2273708 rhabdomyosarcoma (RD) cell line 2287440 Human Umbilical Vein Endothelial Cell 2507026 CAMA1Ee 2508529 HSC172 (60PDL) 2514812 KM12C(HCC)-parental human colon carcinoma 2514988 Human colon adenocarcinoma;ATCC HTB 37 2518024 KM12C(HCC)metastasis into mouse (liver) 2620302 Clonetics 4075 2899153 H9 2912856 T84 (ATCC number CCL-248) 3212672 NSTH II 3600461 myeloid leukemia HL-60 3601542 PCI-O6B 3601568 exocervical cells 3601691 23132 gastric carcinoma cell line 3601728 SK-ER3 3601828 primary cell culture 3601846 Clonetics Corp. (San Diego, CA) strain #68 and 3601882 KM3 3602043 melanoma UACC-903 3602085 GM-CSF-deprived TF-1 cell line 3602227 HS74 and its SV40-transformed sublines 3750771 K562 (erythro-leukemic) 3750994 T Lymphoblastoid cell line ATCC#CCL119